Powerful Medical Secures €7.5M in Funding from European Innovation Council to Revolutionize Heart Attack Diagnostics with AI
AALST, Belgium, March 01, 2024 (GLOBE NEWSWIRE) -- Powerful Medical leads the battle against cardiovascular diseases, the number one cause of death worldwide, with heart attacks accounting for the majority of these fatalities. The company's flagship AI-powered ECG interpretation platform, PMcardio, is setting a new standard in cardiac diagnostics, enabling healthcare professionals to detect acute heart attacks, also known as occlusion myocardial infarction, along with 38 other cardiac abnormalities at the first point of contact. The certified medical device analyzes any image of a 12-lead ECG and compares it against millions of previous patient records, enabling early and precise diagnosis—a critical gap in current healthcare practices.
- Powerful Medical, a pioneering medical device manufacturer, proudly announces being selected to receive a €2.5 million grant and a follow-on €5 million investment from the European Innovation Council (EIC) .
- Chosen from over one thousand applicants , Powerful Medical stands out as a driver of innovation focused on transforming the field of cardiovascular diagnostics.
- Backed by the European Innovation Council, Powerful Medical is escalating its clinical validation efforts and expanding its footprint throughout Europe.
- Their commitment to innovation and improving patient care establishes Powerful Medical as a key player in transforming heart care with AI on a worldwide scale.